Top compounds associated with response to DLST


Feature Type Standardized
Nominal ANOVA
mRNA cediranib CTRPv2 pan-cancer AAC -0.029 0.6
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC -0.018 0.6
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.016 0.6
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.029 0.6
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.023 0.6
mRNA CAL-101 GDSC1000 pan-cancer AAC -0.016 0.6
mRNA NU-7441 GDSC1000 pan-cancer AAC 0.019 0.6
mRNA Methotrexate FIMM pan-cancer AAC -0.069 0.6
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.6
Download CSV